Auspogen Injection 300ug

About Auspogen Injection 300ug

Auspogen Injection 300ug Uses

• Neutropenia following chemotherapy sessions
• Slow white blood cell recovery after bone marrow transplant
• Congenital or chronic neutropenia disorders
• Infection risk reduction during cancer therapy
• Stem cell collection before transplant procedures

Auspogen Injection 300ug Benefits

• Quicker rebound of neutrophil levels post chemotherapy
• Reduced hospital admissions from infection during treatment
• Support for completing full chemotherapy cycles on schedule
• Established use in bone marrow transplant recovery protocols
• Widely used biologic across major oncology centers

Oncology units in Lahore, Karachi, Islamabad, and Rawalpindi commonly use Auspogen Injection 300ug for chemotherapy patients with falling white blood cell counts. It helps patients stay on track with their treatment plans.

The injection encourages the bone marrow to release more neutrophils into the bloodstream. Stronger neutrophil counts mean better protection against infection during vulnerable treatment phases.

This medicine is never given without direct medical supervision. Blood tests and dose timing should be managed only by the treating specialist.

Drug Class

• Granulocyte colony stimulating factor (G CSF)
• Recombinant hematopoietic agent
• Biologic immune support therapy

Auspogen Injection 300ug formula

• Filgrastim

Available forms

• Injection

How to use Auspogen Injection 300ug?

• Injection given subcutaneously by a nurse or doctor, usually once daily during the treatment course.
• Dose calculation based on body weight and the severity of neutropenia.
• Refrigerated storage of the syringe until just before use.
• Blood count checks scheduled regularly to guide further dosing.
• Immediate reporting of unusual bone pain, fever, or breathlessness.

Drug Interactions

Auspogen Injection 300ug has a limited interaction profile, but scheduling around cancer treatment is important. The treating doctor coordinates timing with other medicines.

• Chemotherapy Agents: At least 24 hours' separation kept from chemotherapy doses to avoid reduced effect.
• Radiotherapy: Timing adjusted carefully when combined with radiation sessions.
• Lithium: Possible increase in neutrophil release, requiring monitoring by the doctor.

Risks and warnings

• Spleen Enlargement: Possible complication, with abdominal pain as the main early sign.
• Hypersensitivity: Rare but serious allergic reactions can occur during or after injection.
• Sickle Cell Disorders: Increased risk of painful sickle cell crises in affected patients.
• Respiratory Distress: Rare cases of lung related breathing difficulty reported.
• Long Term Monitoring: Regular checkups needed for patients on extended therapy.

Side Effects

Mild bone discomfort is a typical response to this injection. Symptoms usually settle without specific treatment.

• Bone and muscle pain
• Mild fever
• Headache
• Loss of appetite
• General tiredness

Severe reactions are uncommon but should never be ignored. Immediate medical care is needed if these symptoms appear.

• Sudden severe pain in the upper abdomen or shoulder
• Swelling of the face, lips, or throat
• Trouble breathing
• Unusual bruising or bleeding

Storage Conditions

Keep refrigerated at 2°C to 8°C and avoid shaking or freezing the syringe. Protect from light and dispose of any unused portion safely.